ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2734

Is Disease Activity Associated with Negative Illness Perceptions in Early Axial Spondyloarthritis Patients in the Spondyloarthritis Caught Early (SPACE)-Cohort?

Miranda van Lunteren1, Margreet Scharloo2, Ad Kaptein3, Zineb Ez-Zaitouni1, Pauline Bakker1, Camilla Fongen4, Robert Landewé5, Maikel van Oosterhout6, Mariagrazia Lorenzin7, Désirée van der Heijde1 and Floris van Gaalen1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Medical Psychology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 6Rheumatology, Groene Hart Ziekenhuis, Gouda, Netherlands, 7Rheumatology Unit, Department of Medicine DIMED, Rheumatology Unit,University of Padova, Padova, Italy

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disease Activity and axial spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Studies in patients with rheumatic diseases report that negative views of illness are associated with poorer disease outcomes, such as more disability and pain. Little is known about illness perceptions in patients with early axial Spondyloarthritis (axSpA). The aim is to describe illness perceptions and to explore the association with disease activity in patients with early axSpA at baseline.

Methods: The SPACE-cohort includes patients (chronic back pain ≥3 months, ≤2 years, onset <45 years) recruited from 5 participating centers in Europe. Patients completed the Revised Illness Perception Questionnaire (IPQ-R). The illness identity dimension asked patients if they have experienced a certain symptom (15 in total) and if they believed these symptoms are related to axSpA. The other illness perception dimensions (7 dimensions) and causal attributions (5 dimensions) used 5-point Likert scales to score all items ranging from 1 (strongly disagree) to 5 (strongly agree). For the IPQ-R dimensions, see Table 1. Disease activity was assessed by ASDAS (Ankylosing Spondylitis Disease Activity Score, CRP based). Univariable linear regression models were built for each IPQ-R dimension as dependent and ASDAS as independent variable adjusted for age and gender.

Results were stratified when gender was an effect modifier (p<0.20). P-values <0.05 were considered to be statistically significant.

Results: Only patients fulfilling the ASAS classification for axSpA (n=162/400) were included. Patients had a mean age of 30.0 (SD 8.0) years and 51.9% were male. The mean disease duration was 13.9 (SD 8.1) months and the mean ASDAS 2.5 (SD 0.9). Patients reported on average 4.3 (SD 2.3) symptoms to be associated with axSpA on average (Table 1). Pain, joint stiffness, fatigue, and sleeping problems were the most reported symptoms according to patients in the illness identity dimension. All other dimensions showed a mean of approximately 3, except psychological attributions, risk factors, immunity, and accident of the causal section, which had a mean of approximately 2. Patients with axSpA attributed their complaints mostly to heredity, chance and bad luck. Three dimensions of the IPQ-R were associated with ASDAS. A higher ASDAS was statistically significantly associated in all patients with stronger beliefs in severe consequences (β=0.26, p<0.001), more negative emotions towards their complaints (β=0.18, p=0.027), and in women with more symptoms attributed to axSpA (β=1.53, p<0.001). There was a trend between a higher ASDAS and less belief in personal control (β=-0.10, p=0.082) and less illness coherence (β=-0.13, p=0.083).

Conclusion: In patients with early axSpA, disease activity is associated with negative illness perceptions, such as attribution of multiple symptoms, believing in severe consequences, and experiencing negative emotions towards axSpA.


Disclosure: M. van Lunteren, None; M. Scharloo, None; A. Kaptein, None; Z. Ez-Zaitouni, None; P. Bakker, None; C. Fongen, None; R. Landewé, None; M. van Oosterhout, None; M. Lorenzin, None; D. van der Heijde, None; F. van Gaalen, None.

To cite this abstract in AMA style:

van Lunteren M, Scharloo M, Kaptein A, Ez-Zaitouni Z, Bakker P, Fongen C, Landewé R, van Oosterhout M, Lorenzin M, van der Heijde D, van Gaalen F. Is Disease Activity Associated with Negative Illness Perceptions in Early Axial Spondyloarthritis Patients in the Spondyloarthritis Caught Early (SPACE)-Cohort? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/is-disease-activity-associated-with-negative-illness-perceptions-in-early-axial-spondyloarthritis-patients-in-the-spondyloarthritis-caught-early-space-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-disease-activity-associated-with-negative-illness-perceptions-in-early-axial-spondyloarthritis-patients-in-the-spondyloarthritis-caught-early-space-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology